Commentary: The quest for an improved risk stratification tool for patients with melanoma - 18/04/17
Doi : 10.1016/j.jaad.2017.02.045
Michael E. Ming, MD, MSCE ⁎ 
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
∗Correspondence to: Michael E. Ming, MD, MSCE, Department of Dermatology, University of Pennsylvania Health System, 3600 Spruce St, 2 Maloney Bldg, Philadelphia, PA 19104.Department of DermatologyUniversity of Pennsylvania Health System3600 Spruce St, 2 Maloney BldgPhiladelphiaPA19104
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the author. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 76 - N° 5
P. 826-828 - mai 2017 Retour au numéro
Article précédent
- Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification
- Laura K. Ferris, Aaron S. Farberg, Brooke Middlebrook, Clare E. Johnson, Natalie Lassen, Kristen M. Oelschlager, Derek J. Maetzold, Robert W. Cook, Darrell S. Rigel, Pedram Gerami
- Factors influencing and modifying the decision to pursue genetic testing for skin cancer risk
- Alexander L. Fogel, Prajakta D. Jaju, Shufeng Li, Bonnie Halpern-Felsher, Jean Y. Tang, Kavita Y. Sarin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?